Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Freed whale gets stranded again off German coast - 2Living Abroad: Social Inundation and Self-improvement
- 3James Webb Space Telescope watches our Milky Way galaxy's monster black hole fire out a flare
- 4Women take pride in Holy Week roles after a Spanish Catholic brotherhood's procession excluded them
- 5How do my eyes adjust to the dark and how long does it take?
- Tanzania president remorseful over internet shutdown on election day
- Meet the astronauts about to make history on flight around the moon
- IDF strikes Tehran command centers, weapon production sites
- When a sperm whale gives birth, the mother gets help from her friends
- Israel violated ceasefire with Hezbollah more than 10,000 times, UNIFIL claims
- Knesset sets special panel to fast-track Karhi’s communications reform
- US FDA panel to weigh bid to market nicotine pouches as lower-risk than cigarettes
- Police arrest 18 as anti-war protests spread across Tel Aviv, Haifa, Jerusalem
- It Shouldn’t Be Here: Rescuers Race to Save Whale Stranded in Rare Spot
